REDPOINT BIO CORPORATION

Press Releases Redpoint Bio Corporation

Equities

RPBC

US7577361030

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2013	Redpoint Bio Corporation cancelled the transaction announced on July 16, 2012.	CI
2012	Redpoint Bio Corporation cancelled the acquisition of Celator Pharmaceuticals, Inc. from Domain Associates, L.L.C., BDC Diversified Venture Fund of BDC Venture Capital, GrowthWorks Access Fund Limited Partnership of Matrix Asset Management Inc., Quaker BioVentures, Thomas, McNerney & Partners, TL Ventures, Ventures West Management Inc. and others.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

REDPOINT BIO CORP : Redpoint Bio Reports Three Months and Nine Months Ended September 30, 2010 Results	10-11-09	PR
REDPOINT BIO CORP : Redpoint Announces Generally Recognized As Safe (GRAS) Determination for RP44 Sweetness Enhancer	10-11-03	PR
REDPOINT BIO CORP : Redpoint Bio to Present at Rodman & Renshaw Annual Global Investment Conference	10-09-07	PR
REDPOINT BIO CORP : Redpoint Bio Reports Three Months and Six Months Ended June 30, 2010 Results	10-08-13	PR
REDPOINT BIO CORP : Redpoint Bio Receives U.S. Patent Covering Screening Technology	10-07-28	PR
REDPOINT BIO CORP : Redpoint Signs License and Commercialization Agreement with International Flavors & Fragrances	10-06-30	PR
REDPOINT BIO CORP : Redpoint Bio Reports First Quarter 2010 Results	10-05-14	BU
REDPOINT BIO CORP : The Trout Group LLC and BioBusiness.TV Team to Produce '60 Second Pitch' Videos for Biotechnology Companies	10-02-01	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer